Cargando…
Deriving protein binding‐corrected chemical concentrations for in vitro testing
Extracellular chemical concentrations are considered physiologically relevant for in vitro testing and are evaluated in traditional in vitro systems using cell culture media containing 5%–10% fetal bovine serum (FBS). However, depending on the physicochemical properties, and in vitro testing conditi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651662/ https://www.ncbi.nlm.nih.gov/pubmed/37605430 http://dx.doi.org/10.1111/cts.13616 |
_version_ | 1785136040376270848 |
---|---|
author | Kolli, Aditya R. |
author_facet | Kolli, Aditya R. |
author_sort | Kolli, Aditya R. |
collection | PubMed |
description | Extracellular chemical concentrations are considered physiologically relevant for in vitro testing and are evaluated in traditional in vitro systems using cell culture media containing 5%–10% fetal bovine serum (FBS). However, depending on the physicochemical properties, and in vitro testing conditions, cells could be exposed to variable unbound extracellular concentrations. If in vitro unbound concentrations are not calculated, it is challenging to distinguish the chemical potency and concentration‐driven responses. In this study, one‐ and two‐protein binding models were used to estimate protein binding corrected chemical concentrations of various chemicals for in vitro testing. As ceftizoxime, moxifloxacin, and nicotine have low protein binding affinity, the in vitro protein binding in 5%–10% FBS is less than 5% and can be considered negligible. However, protein binding of moderate and highly protein‐bound chemicals must be corrected for as the in vitro unbound concentrations in 5%–10% FBS containing cell culture media will vary over a range of chemical concentrations. In vitro pharmacological and toxicological assessments must incorporate protein binding‐adjusted in vitro concentrations to ensure physiologically relevant exposures. A user‐friendly Excel spreadsheet is provided to help bench scientists calculate protein binding‐corrected chemical concentrations for in vitro testing. |
format | Online Article Text |
id | pubmed-10651662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106516622023-08-28 Deriving protein binding‐corrected chemical concentrations for in vitro testing Kolli, Aditya R. Clin Transl Sci Research Extracellular chemical concentrations are considered physiologically relevant for in vitro testing and are evaluated in traditional in vitro systems using cell culture media containing 5%–10% fetal bovine serum (FBS). However, depending on the physicochemical properties, and in vitro testing conditions, cells could be exposed to variable unbound extracellular concentrations. If in vitro unbound concentrations are not calculated, it is challenging to distinguish the chemical potency and concentration‐driven responses. In this study, one‐ and two‐protein binding models were used to estimate protein binding corrected chemical concentrations of various chemicals for in vitro testing. As ceftizoxime, moxifloxacin, and nicotine have low protein binding affinity, the in vitro protein binding in 5%–10% FBS is less than 5% and can be considered negligible. However, protein binding of moderate and highly protein‐bound chemicals must be corrected for as the in vitro unbound concentrations in 5%–10% FBS containing cell culture media will vary over a range of chemical concentrations. In vitro pharmacological and toxicological assessments must incorporate protein binding‐adjusted in vitro concentrations to ensure physiologically relevant exposures. A user‐friendly Excel spreadsheet is provided to help bench scientists calculate protein binding‐corrected chemical concentrations for in vitro testing. John Wiley and Sons Inc. 2023-08-28 /pmc/articles/PMC10651662/ /pubmed/37605430 http://dx.doi.org/10.1111/cts.13616 Text en © 2023 The Author. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Kolli, Aditya R. Deriving protein binding‐corrected chemical concentrations for in vitro testing |
title | Deriving protein binding‐corrected chemical concentrations for in vitro testing |
title_full | Deriving protein binding‐corrected chemical concentrations for in vitro testing |
title_fullStr | Deriving protein binding‐corrected chemical concentrations for in vitro testing |
title_full_unstemmed | Deriving protein binding‐corrected chemical concentrations for in vitro testing |
title_short | Deriving protein binding‐corrected chemical concentrations for in vitro testing |
title_sort | deriving protein binding‐corrected chemical concentrations for in vitro testing |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651662/ https://www.ncbi.nlm.nih.gov/pubmed/37605430 http://dx.doi.org/10.1111/cts.13616 |
work_keys_str_mv | AT kolliadityar derivingproteinbindingcorrectedchemicalconcentrationsforinvitrotesting |